Condições
16 condições de saúde com pesquisa de suplementos baseada em evidências
We evaluate supplements across specific hair and scalp conditions. Each condition page ranks ingredients by evidence grade, helping you find what research actually supports for your particular concern.
How We Grade Evidence
Cada página de condição classifica os ingredientes de suplementos pela força da evidência clínica. Veja o que cada nota significa:
Strong Evidence
Multiple randomized controlled trials (RCTs) or meta-analyses with consistent positive results and large sample sizes.
Good Evidence
At least one RCT with mostly consistent results across studies. Evidence suggests benefit but more research may be needed.
Some Evidence
Small studies or observational data with some positive signals. Promising but insufficient for strong recommendations.
Very Early Research
In vitro studies, case reports, or pilot studies only. Early-stage research that requires clinical validation.
Afinamento Capilar Relacionado à Idade
Near-universal over age 60
Alopecia Androgenética
50% of men by age 50, 25% of women by age 50
Alopecia Areata
2% lifetime risk
Alopecia por Tração
Common in certain hairstyle practices
Perda Capilar de Padrão Feminino
40% of women by age 50
Perda Capilar por Deficiência de Ferro
Affects up to 60% of premenopausal women with hair loss
Perda Capilar por Deficiência Nutricional
Common in restrictive diets and malabsorption conditions
Perda Capilar por Estresse
Increasingly common; associated with telogen effluvium
Perda Capilar por Psoríase do Couro Cabeludo
45-56% of psoriasis patients have scalp involvement
Perda Capilar Pós-Parto
Affects 40-50% of women postpartum
Perda Capilar Relacionada à Tireoide
4-10% of general population has thyroid dysfunction
Telogen Effluvium
Second most common cause of hair loss
Chemotherapy-Induced Hair Loss
Affects 65-85% of chemotherapy patients depending on regimen
Hormonal Hair Changes (PCOS & Menopause)
PCOS affects 6-12% of women; menopause-related thinning affects 40%+ of postmenopausal women
Brittle Hair and Nails Syndrome
Affects approximately 20% of the general population
Scalp Inflammation (Folliculitis & Dermatitis)
Seborrheic dermatitis affects 3-5% of adults; scalp involvement very common
Aviso Legal da FDA: Estas declarações não foram avaliadas pela Food and Drug Administration. Os produtos e informações neste site não se destinam a diagnosticar, tratar, curar ou prevenir qualquer doença. As notas de evidência apresentadas são baseadas em nossa análise de pesquisas revisadas por pares publicadas e não constituem aconselhamento médico. Sempre consulte seu profissional de saúde antes de iniciar qualquer regime de suplementação.